CClinicalTrials.gg
CompletedNCT02251574Updated Apr 5, 2018

Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults

An interventional study of Low Calorie Diet and Very Low Calorie Diet in Obstructive Sleep Apnea, sponsored by University of Kansas Medical Center. Completed at 1 site in United States. Open to participants aged 21 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-05.

Sponsored by University of Kansas Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
37
Allocation
Randomized
Ages
21 Years to 75 Years
Sex
All
01

Study summary

The purpose of this study is to test the effectiveness of two different weight loss diets on obstructive sleep apnea (OSA) severity.

Read the detailed description

Sleep apnea is a sleep disorder in which breathing repeatedly stops and starts during sleep. The most common type is obstructive sleep apnea (OSA), which occurs when the muscles in your throat relax and block your airway during sleep. The most noticeable sign of OSA is snoring. OSA is a risk factor for other chronic conditions like type 2 diabetes, cardiovascular disease, and high blood pressure.

Although anyone can develop OSA, it commonly affects people who are obese. The more someone weighs, the more likely the OSA is to be severe. Weight loss is typically recommended for overweight individuals to help improve OSA. However, not enough research has been done for doctors to be able make specific recommendations to their patients.

02

Conditions studied

03

In context

Apnea

1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.

This study's enrollment of 37 is below the median of 50 across 965 interventional studies indexed under Apnea.

Browse Apnea studies →

Lead sponsor

University of Kansas Medical Center is the lead sponsor of 483 studies on the registry; 113 are open to participants now.

Of its 38 completed or terminated interventional studies of FDA-regulated products, 24 (63%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • AHI score of ≥ 5
  • Body mass index (BMI) between 30 to 49.9 kg/m2

Exclusion criteria

Exclusion Criteria:

  • Report serious medical risk such as insulin-dependent diabetes, active cancer, recent cardiac event
  • Currently or planning to become pregnant during the next 9 months
  • Not weight stable (-4.6 kg) for 3 mos. prior to intake
  • Report current participation in a weight reduction program involving diet or PA
  • Unwilling to be randomized to 1 of 3 study groups
  • Report symptomology of an eating disorder as determined by the Eating Attitudes Test
  • Unable to participate in moderate intensity physical activity
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
37 participants (actual)

Study arms

  • Experimental
    Low Calorie Diet

    Participants will take part in an experimental weight management program involving a low calorie diet (LCD), about 1200-1500 calories per day.

    Other: Low Calorie Diet

  • Experimental
    Very Low Calorie Diet

    Participants will take part in an experimental weight management program involving a low calorie diet (LCD), about 520-800 calories per day.

    Other: Very Low Calorie Diet

  • Active comparator
    Standard Care

    Participants will receive normal care.

    Other: Standard Care

Interventions

  • OtherLow Calorie Diet

    Weight management program designed around a low calorie diet.

  • OtherVery Low Calorie Diet

    Weight management program designed around a very low calorie diet.

  • OtherStandard Care

    Care provided that would normally be given to people meeting eligibility criteria for this study.

06

What researchers measure

Primary outcomes

  1. Change in Apnea Hypopnea Index (AHI)

    The AHI measures sleep apnea severity and represents the number of apnea and hypopnea events per hour.

    Time frame: Change from Baseline to Month 3

Secondary outcomes

  1. Change in Apnea Hypopnea Index (AHI)

    The AHI measures sleep apnea severity and represents the number of apnea and hypopnea events per hour.

    Time frame: Change from Baseline to Month 9

  2. Change in metabolic syndrome (MetS) risk factors

    Risk factors to be measured include waist circumference, triglycerides, HDL-cholesterol, blood pressure, fasting glucose

    Time frame: Change from Baseline to Month 3 and Month 9

  3. Change in Quality of Life

    Participants will complete the Calgary Sleep Apnea Quality of Life Index (SAQLI) that will assess participants response to the intervention/treatment.

    Time frame: Change from Baseline to Month 3 and Month 9

  4. Change in Daytime Sleepiness

    Researchers will administer Epworth Sleepiness Scale. Results will be used to calculate daytime sleepiness changes for each participant.

    Time frame: Change from Baseline to Month 3 and Month 9

07

Study locations

1 site
  • University of Kansas Medical Center
    Kansas City, Kansas 66160, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02251574
Lead sponsor
University of Kansas Medical Center
Responsible party
Sponsor
First posted
Sep 29, 2014
Start date
Sep 2014
Primary completion
Jun 2016
Completion
Jun 2016
Last update
Apr 5, 2018

Study contacts

Jeannine Goetz, PhD
principal investigator · University of Kansas Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion